4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Endothelial Pannexin 1 Channels Control Inflammation by Regulating Intracellular Calcium

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="P3">The proinflammatory cytokine IL-1β is a significant risk factor in cardiovascular disease that can be targeted to reduce major cardiovascular events. IL-1β expression and release are tightly controlled by changes in intracellular Ca <sup>2+</sup> [Ca <sup>2+</sup>] <sub>i</sub> which has been associated with ATP release and purinergic signaling. Despite this, the mechanisms that regulate these changes have not been identified. The pannexin 1 (Panx1) channels have canonically been implicated in ATP release, especially during inflammation. We examined Panx1 in human umbilical vein endothelial cells (HUVECs) following treatment with the pro-inflammatory cytokine tumor necrosis alpha (TNF). Analysis by whole transcriptome sequencing (RNA-seq) and immunoblot, identified a dramatic increase in Panx1 mRNA and protein expression that is regulated in an NFκβ-dependent manner. Furthermore, genetic inhibition of Panx1 reduced the expression and secretion of IL-1β. We initially hypothesized that increased Panx1-mediated ATP release acted in a paracrine fashion to control cytokine expression. However, our data demonstrate that IL-1β expression was not altered after direct ATP stimulation in HUVECs. Because Panx1 forms a large pore channel, we hypothesized it may permit Ca <sup>2+</sup> diffusion into the cell to regulate IL-1β. High-throughput flow cytometric analysis demonstrated that TNF treatments lead to elevated [Ca <sup>2+</sup>] <sub>i</sub> corresponding with Panx1 membrane localization. Genetic or pharmacological inhibition of Panx1 reduced TNF-associated increases in [Ca <sup>2+</sup>] <sub>i</sub>, blocked phosphorylation of the NFκβ-p65 protein and reduced IL-1β transcription. Taken together, our study provides the first evidence that [Ca <sup>2+</sup>] <sub>i</sub> regulation via the Panx1 channel induces a feed-forward effect on NFκβ to regulate IL-1β synthesis and release in endothelium during inflammation. </p>

          Related collections

          Most cited references71

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular mechanisms regulating NLRP3 inflammasome activation.

          Inflammasomes are multi-protein signaling complexes that trigger the activation of inflammatory caspases and the maturation of interleukin-1β. Among various inflammasome complexes, the NLRP3 inflammasome is best characterized and has been linked with various human autoinflammatory and autoimmune diseases. Thus, the NLRP3 inflammasome may be a promising target for anti-inflammatory therapies. In this review, we summarize the current understanding of the mechanisms by which the NLRP3 inflammasome is activated in the cytosol. We also describe the binding partners of NLRP3 inflammasome complexes activating or inhibiting the inflammasome assembly. Our knowledge of the mechanisms regulating NLRP3 inflammasome signaling and how these influence inflammatory responses offers further insight into potential therapeutic strategies to treat inflammatory diseases associated with dysregulation of the NLRP3 inflammasome.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            TNF-mediated inflammatory disease.

            JR Bradley (2008)
            TNF was originally described as a circulating factor that can cause necrosis of tumours, but has since been identified as a key regulator of the inflammatory response. This review describes the known signalling pathways and cell biological effects of TNF, and our understanding of the role of TNF in human disease. TNF interacts with two different receptors, designated TNFR1 and TNFR2, which are differentially expressed on cells and tissues and initiate both distinct and overlapping signal transduction pathways. These diverse signalling cascades lead to a range of cellular responses, which include cell death, survival, differentiation, proliferation and migration. Vascular endothelial cells respond to TNF by undergoing a number of pro-inflammatory changes, which increase leukocyte adhesion, transendothelial migration and vascular leak and promote thrombosis. The central role of TNF in inflammation has been demonstrated by the ability of agents that block the action of TNF to treat a range of inflammatory conditions, including rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease and psoriasis. The increased incidence of infection in patients receiving anti-TNF treatment has highlighted the physiological role of TNF in infectious diseases. 2007 Pathological Society of Great Britain and Ireland
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

              Canakinumab, a monoclonal antibody targeting interleukin (IL)-1β, reduces rates of recurrent cardiovascular events without lowering lipids. It is uncertain, however, to what extent these beneficial cardiovascular outcomes are mediated through interleukin-6 (IL-6) signalling, an issue with substantial pathophysiologic consequences and therapeutic implications.
                Bookmark

                Author and article information

                Journal
                The Journal of Immunology
                J.I.
                The American Association of Immunologists
                0022-1767
                1550-6606
                May 18 2020
                June 01 2020
                June 01 2020
                April 20 2020
                : 204
                : 11
                : 2995-3007
                Article
                10.4049/jimmunol.1901089
                7336877
                32312847
                2b9ef3b8-2a1b-4976-ac28-a1931f70095e
                © 2020
                History

                Comments

                Comment on this article